Erratum: Leptin Modulates Allograft Survival by Favoring a Th2 and a Regulatory Immune Profile (American Journal of Transplantation 13 (36-44) DOI: 10.1111/j.1600-6143.2012.04283.x);Leptin modulates allograft survival by favoring a Th2 and a regulatory immune profile

American Journal of Transplantation

Volumn 13, Issue 1, 2013, Pages 36-44

  Moraes Vieira, P M M ^a   Bassi, E J ^a   Larocca, R A ^d   Castoldi, A ^a   Burghos, M ^a   Lepique, A P ^a   Quintana, F J ^c   Araujo, R C ^b   Basso, A S ^b   Strom, T B ^d   Camara N O S ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c Brigham and Women's Hospital Center for Neurologic Diseases   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Alloimmunity; leptin; regulatory T cell; tolerance

Indexed keywords

LEPTIN;

ALLOTRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; GRAFT SURVIVAL; IMMUNE RESPONSE; LEPTIN DEFICIENCY; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SKIN GRAFT; SKIN TRANSPLANTATION; TH2 CELL; WILD TYPE;

EID: 84871719656     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12421     Document Type: Erratum

References (28)

1. Kahn BB, Flier JS,. Obesity and insulin resistance. J Clin Invest 2000; 106: 473-481.
2. Karlsson EA, Beck MA,. The burden of obesity on infectious disease. Exp Biol Med (Maywood); 235: 1412-1424.
3. La Cava A, Matarese G,. The weight of leptin in immunity. Nat Rev Immunol 2004; 4: 371-379.
4. Bozkurt A, Cakir B, Ercan F, Yegen BC,. Anti-inflammatory effects of leptin and cholecystokinin on acetic acid-induced colitis in rats: Role of capsaicin-sensitive vagal afferent fibers. Regul Pept 2003; 116: 109-118.
5. Siegmund B, Lear-Kaul KC, Faggioni R, Fantuzzi G,. Leptin deficiency, not obesity, protects mice from Con A-induced hepatitis. Eur J Immunol 2002; 32: 552-560.
6. De Rosa V, Procaccini C, La Cava A, et al.. Leptin neutralization interferes with pathogenic T cell autoreactivity in autoimmune encephalomyelitis. J Clin Invest 2006; 116: 447-455.
7. Matarese G, Sanna V, Lechler RI, et al.. Leptin accelerates autoimmune diabetes in female NOD mice. Diabetes 2002; 51: 1356-1361.
8. Matarese G, Di Giacomo A, Sanna V, et al.. Requirement for leptin in the induction and progression of autoimmune encephalomyelitis. J Immunol 2001; 166: 5909-5916.
9. Taleb S, Herbin O, Ait-Oufella H, et al.. Defective leptin/leptin receptor signaling improves regulatory T cell immune response and protects mice from atherosclerosis. Arterioscler Thromb Vasc Biol 2007; 27: 2691-2698.
10. De Rosa V, Procaccini C, Cali G, et al.. A key role of leptin in the control of regulatory T cell proliferation. Immunity 2007; 26: 241-255.
11. Bjorbaek C, Kahn BB,. Leptin signaling in the central nervous system and the periphery. Recent Prog Horm Res 2004; 59: 305-331.
12. Markees TG, Phillips NE, Noelle RJ, et al.. Prolonged survival of mouse skin allografts in recipients treated with donor splenocytes and antibody to CD40 ligand. Transplantation 1997; 64: 329-335.
13. Macia L, Delacre M, Abboud G, et al.. Impairment of dendritic cell functionality and steady-state number in obese mice. J Immunol 2006; 177: 5997-6006.
14. Zhang N, Schroppel B, Lal G, et al.. Regulatory T cells sequentially migrate from inflamed tissues to draining lymph nodes to suppress the alloimmune response. Immunity 2009; 30: 458-469.
15. Moraes-Vieira PM, Bassi EJ, Araujo RC, Camara NO,. Leptin as a link between the immune system and kidney-related diseases: Leading actor or just a coadjuvant ? Obes Rev 2012; 13: 733-743.
16. Kalaitzidis RG, Siamopoulos KC,. The role of obesity in kidney disease: Recent findings and potential mechanisms. Int Urol Nephrol 2011; 43: 771-784.
17. Papalia T, Greco R, Lofaro D, Maestripieri S, Mancuso D, Bonofiglio R,. Impact of body mass index on graft loss in normal and overweight patients: Retrospective analysis of 206 renal transplants. Clin Transplant 2010; 24: E241-E246.
18. Ditonno P, Lucarelli G, Impedovo SV, et al.. Obesity in kidney transplantation affects renal function but not graft and patient survival. Transplant Proc 2011; 43: 367-372.
19. Waaga AM, Gasser M, Kist-van Holthe JE, et al.. Regulatory functions of self-restricted MHC class II allopeptide-specific Th2 clones in vivo. J Clin Invest 2001; 107: 909-916.
20. Lechler RI, Ng WF, Camara NO,. Infectious tolerance? Mechanisms and implications. Transplantation 2001; 728 Suppl: S29-S31.
21. Waldmann H, Graca L, Cobbold S, Adams E, Tone M, Tone Y,. Regulatory T cells and organ transplantation. Semin Immunol 2004; 16: 119-126.
22. Jarvinen LZ, Blazar BR, Adeyi OA, Strom TB, Noelle RJ,. CD154 on the surface of CD4+CD25+ regulatory T cells contributes to skin transplant tolerance. Transplantation 2003; 76: 1375-1379.
23. Procaccini C, De Rosa V, Galgani M, et al.. An oscillatory switch in mTOR kinase activity sets regulatory T cell responsiveness. Immunity 2010; 33: 929-941.
24. Bettelli E, Carrier Y, Gao W, et al.. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006; 441: 235-238.
25. Mucida D, Park Y, Kim G, et al.. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 2007; 317: 256-260.
26. Chadha R, Heidt S, Jones ND, Wood KJ,. Th17: Contributors to allograft rejection and a barrier to the induction of transplantation tolerance ? Transplantation; 91: 939-945.
27. Cunnusamy K, Chen PW, Niederkorn JY,. IL-17 promotes immune privilege of corneal allografts. J Immunol; 185: 4651-4658.
28. Vokaer B, Van Rompaey N, Lemaitre PH, et al.. Critical role of regulatory T cells in Th17-mediated minor antigen-disparate rejection. J Immunol; 185: 3417-3425.